000			02150nam a2200433 i 4500
999			_c260665 _d260665
001			ocn988946299
003			BD
005			20180426225221.0
006			m o d f
007			cr bn||||a||||
008			170605s2017 dcua ob f000 0 eng c
040			_aPUCPR _beng _erda _epn _cGPO _dGPO _dMvI
042			_apcc
043			_an-us---
049			_aOnline
050	1	4	_aKF26 _b.L277 2014
074			_a1043-C (online)
086	0		_aY 4.L 11/4:S.HRG.113-859
099			_aY 4.L 11/4:S.HRG.113-859
110	1		_aUnited States. _bCongress. _bSenate. _bCommittee on Health, Education, Labor, and Pensions. _bSubcommittee on Primary Health and Aging, _eauthor.
245	1	0	_aWhy are some generic drugs skyrocketing in price? : _bhearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014.
264		1	_aWashington : _bU.S. Government Publishing Office, _c2017.
300			_a1 online resource (iii, 65 pages) : _billustrations.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
490	1		_aS. hrg. ; _v113-859
500			_aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
500			_aCRDP Program record.
504			_aIncludes bibliographical references.
588			_aDescription based on online resource, PDF version; title from title page (FDsys web site, viewed on June 5, 2017).
650		0	_aGeneric drugs _xPrices _zUnited States.
650		0	_aPrescription pricing _zUnited States.
655		7	_aLegislative hearings. _2lcgft
776	0	8	_iPrint version: _aUnited States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Aging. _tWhy are some generic drugs skyrocketing in price? _w(OCoLC)989729813
810	1		_aUnited States. _bCongress. _bSenate. _tS. hrg. ; _v113-859.
856	4	0	_uhttp://purl.fdlp.gov/GPO/gpo81355
942			_2sudocs _c8